Asset
Avutometinib
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05187169 | phase1 | completed | 2021-12-16 | 2022-04-12 | Verastem, Inc. | Food Effect of VS-6766 in Healthy Adult Subjects |
FDA applications (0)
This company has no applications containing this asset.